General Court agrees with pharma complaint rejection despite error
Credit: iStock/Jorisvo
The EU General Court has found that the European Commission acted legally when it ultimately rejected a complaint alleging anticompetitive dual pricing in the pharmaceutical market, despite it misinterpreting a previous judgment on the enforcer’s 2001 decision.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now